Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection.

Source:http://linkedlifedata.com/resource/pubmed/id/18602438

Vaccine 2008 Sep 8 26 38 4893-903

Download in:

View as

General Info

PMID
18602438